Mutations or silenced expression of MYO18B was subsequently found in ovarian cancers (Yanaihara et al., 2004), colorectal cancers (Nakano et al., 2005), melanoma and pancreatic ductal adenocarcinoma (Bleeker et al., 2009), and neuroendocrine cancer (Bhatla et al., 2016). This evidence concerns the gene MYO18B and ovarian carcinoma.